Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.61 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22654529 | 1.00 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL14380937 | 0.97 | DNM1 (0.58) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL114432 | 0.95 | DNM1 (0.57) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL5532689 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL8345191 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL17263911 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL18051492 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL11189857 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL11181978 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 | |
| SCHEMBL11187145 | 0.90 | DNM1 (0.61) | DNM1LPAR1LPAR3LPAR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11649410-B2 | Bioderived fuels and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-05-16 | — | — | US | claimed |
| US-20210340452-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2021-11-04 | — | — | US | claimed |
| US-20200360904-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2020-11-19 | — | — | US | claimed |
| US-11649410-B2 | Bioderived fuels and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-05-16 | — | — | US | disclosed |
| US-11649410-B2 | Bioderived fuels and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-05-16 | — | — | US | disclosed |
| US-11649410-B2 | Bioderived fuels and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-05-16 | — | — | US | disclosed |
| US-20210340452-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2021-11-04 | — | — | US | disclosed |
| US-20210340452-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2021-11-04 | — | — | US | disclosed |
| US-20200360904-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2020-11-19 | — | — | US | disclosed |
| US-20200360904-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | Alliance for Energy Innovation, LLC | 2020-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340452-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | BPGM, HAO2, PLCG1 | DNM1 812/4885LPAR1 99/4885LPAR3 353/4885 |
| US-11649410-B2 | Bioderived fuels and methods of making the same | BPGM, HAO2, PLCG1 | DNM1 812/4885LPAR1 99/4885LPAR3 353/4885 |
| US-20200360904-A1 | BIODERIVED FUELS AND METHODS OF MAKING THE SAME | BPGM, HAO2, PLCG1 | DNM1 812/4885LPAR1 99/4885LPAR3 353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.